Wilson K, He J
Aging Dis. 2023; 14(1):152-169.
PMID: 36818564
PMC: 9937695.
DOI: 10.14336/AD.2022.0712.
Martinez L, Milanic M, Malaina I, Alvarez C, Perez M, De la Fuente I
PLoS One. 2019; 14(2):e0211714.
PMID: 30735507
PMC: 6368308.
DOI: 10.1371/journal.pone.0211714.
Ding J, Ma L, Zhao J, Xie Y, Zhou J, Li X
J Transl Med. 2019; 17(1):35.
PMID: 30665429
PMC: 6341564.
DOI: 10.1186/s12967-019-1777-7.
Watkins R, Zou W, Denton P, Krisko J, Foster J, Garcia J
Retrovirology. 2013; 10:125.
PMID: 24172637
PMC: 3907037.
DOI: 10.1186/1742-4690-10-125.
Pushker R, Jacque J, Shields D
J Virol. 2010; 84(7):3644-53.
PMID: 20071583
PMC: 2838144.
DOI: 10.1128/JVI.01959-09.
Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
Priceputu E, Hanna Z, Hu C, Simard M, Vincent P, Wildum S
J Virol. 2007; 81(9):4677-93.
PMID: 17314161
PMC: 1900134.
DOI: 10.1128/JVI.02691-06.
CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.
Agopian K, Wei B, Garcia J, Gabuzda D
Virology. 2006; 358(1):119-35.
PMID: 16979207
PMC: 1995023.
DOI: 10.1016/j.virol.2006.07.053.
Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
Crotti A, Neri F, Corti D, Ghezzi S, Heltai S, Baur A
J Virol. 2006; 80(21):10663-74.
PMID: 16943296
PMC: 1641799.
DOI: 10.1128/JVI.02621-05.
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
ONeill E, Kuo L, Krisko J, Tomchick D, Garcia J, Foster J
J Virol. 2006; 80(3):1311-20.
PMID: 16415008
PMC: 1346962.
DOI: 10.1128/JVI.80.3.1311-1320.2006.
Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort.
Mikhail M, Wang B, Lemey P, Beckthold B, Vandamme A, Gill M
Retrovirology. 2005; 2:41.
PMID: 15985187
PMC: 1190217.
DOI: 10.1186/1742-4690-2-41.
Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.
Tsui R, Herring B, Barbour J, Grant R, Bacchetti P, Kral A
J Virol. 2003; 78(1):94-103.
PMID: 14671091
PMC: 303392.
DOI: 10.1128/jvi.78.1.94-103.2004.
CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression.
Casartelli N, Di Matteo G, Potesta M, Rossi P, Doria M
J Virol. 2003; 77(21):11536-45.
PMID: 14557639
PMC: 229262.
DOI: 10.1128/jvi.77.21.11536-11545.2003.
Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors.
Tobiume M, Takahoko M, Yamada T, Tatsumi M, Iwamoto A, Matsuda M
J Virol. 2002; 76(12):5959-65.
PMID: 12021328
PMC: 136235.
DOI: 10.1128/jvi.76.12.5959-5965.2002.
Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP.
Janvier K, Craig H, Le Gall S, Benarous R, Guatelli J, Schwartz O
J Virol. 2001; 75(8):3971-6.
PMID: 11264386
PMC: 114888.
DOI: 10.1128/JVI.75.8.3971-3976.2001.
Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.
Foster J, Molina R, Luo T, Arora V, Huang Y, Ho D
J Virol. 2001; 75(4):1672-80.
PMID: 11160665
PMC: 114076.
DOI: 10.1128/JVI.75.4.1672-1680.2001.
Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.
Khatissian E, Monceaux V, Cumont M, Kieny M, Aubertin A, Hurtrel B
J Virol. 2001; 75(3):1507-15.
PMID: 11152522
PMC: 114055.
DOI: 10.1128/JVI.75.3.1507-1515.2001.
The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo.
Kirchhoff F, Munch J, Carl S, Stolte N, Matz-Rensing K, Fuchs D
J Virol. 1999; 73(10):8371-83.
PMID: 10482588
PMC: 112855.
DOI: 10.1128/JVI.73.10.8371-8383.1999.
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease.
Kirchhoff F, Easterbrook P, Douglas N, Troop M, Greenough T, Weber J
J Virol. 1999; 73(7):5497-508.
PMID: 10364298
PMC: 112607.
DOI: 10.1128/JVI.73.7.5497-5508.1999.
Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.
Grovit-Ferbas K, Ferbas J, Gudeman V, Sadeghi S, Goetz M, Giorgi J
J Virol. 1998; 72(11):8650-8.
PMID: 9765405
PMC: 110277.
DOI: 10.1128/JVI.72.11.8650-8658.1998.
Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice.
Gulizia R, Collman R, Levy J, Trono D, Mosier D
J Virol. 1997; 71(5):4161-4.
PMID: 9094701
PMC: 191576.
DOI: 10.1128/JVI.71.5.4161-4164.1997.